GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 22AC44
Of the Field

CPHI Milan 2026

C

PHI Milan is a leading in-person pharmaceutical industry event convening the global pharma community to advance human health. It provides unrivalled networking opportunities, access to the global supply chain, and solutions to connect and innovate year-round. The event includes hundreds of expert speakers, over 2,900 exhibitors, and comprehensive content se…

Visit the official site
34Voices
3Underwriters
12Exhibitors
1On the bill · sessions
44Companies · in total
§I

The Voices

Programmed at CPHI, in alphabetical order.
Aaron Dely
VP of Research & Development · PLD Pharma Services
Alejandro Córdova Motte
Supply Chain & Access Director · CANIFARMA
Alessandro Gagnoni
Senior Director Pharmaceutical Operations · Kamfarma SA
Amit Limaye
Director · Becton Dickinson & Company (BD)
Anuji Abraham
Senior Director, Pharmaceutical Development · Altasciences
Brent Del Monte
Principal · BGR Group
Brian Beyer
Senior Manager · KPMG
Carrie Bracco
Head Business Development US - CMO · Novartis Contract Manufacturing
Emily George
Account Executive, Customer Growth · EcoVadis
Giorgio Salciarini
Head of Sales- Technical Business Development · BSP Pharmaceuticals
Isis Valle
Regulatory Inteligence for Innovation · Franklin da Costa Attorneys & Consultants
Janak Vadgama
Head of Customer Experience · Qprotyn Inc
Jeffrey Speicher
Commercial General Manager · PLD Pharma Services
John Lowry
Chairman and CEO · Praxis Packaging Solutions
John Nosta
Founder · NOSTALAB
Julia Sable
Director Technical Partnerships and Portfolio Management · Kite Pharmaceuticals
Karen Greene
Partner · Network Partners Group
Karen Kozarsky
President/CSO · Vector BioPartners
Kenneth Yancey
Senior Vice President, CMC · Franklin Biolabs
Lee Evans
Executive Advisor · Network Partners Group
Luke Greenwalt
Vice President · IQVIA
Marie-Hélène Raigneau
Chief Executive Officer · Altasciences

— and 12 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Hetero
KSM
Thermo Fisher
§III

The Programme

Selected from 1 sessions on the bill.
  • June 3, 2026 (Day 2), 1:30 - 2:00pm

    John Nosta book signing

    Join us at CPHI Americas for a book signing with John Nosta, founder of NOSTALAB and author of The Borrowed Mind. A global innovation theorist and top tech influencer, John offers …

Intermission
Part the Second · For the Buyer

What does it mean when 44 companies show up — and 1 bet on three roles at once?

44 companies. one are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
1All threespeak · spons · exh
2Sponsoringsponsor only
11Exhibitingexhibitor only
30Speakingspeaker only

The Triple-Threat

Hetero

02Fig. 02 — The Voices, by Seniority

65% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite515%
  • Founder / Owner39%
  • VP-level515%
  • Director / Head of926%
  • Manager / Lead412%
  • Research / Science13%
  • Advisor / Investor13%
  • Other roles618%

Of 34 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01HeteroSpEx
  2. 02KSMSp
  3. 03Thermo FisherSp
  4. 04Altasciences2V
  5. 05BDEx
  6. 06BD Advancing the world of healthEx
  7. 07GerresheimerEx
  8. 08HonourEx
  9. 09LonzaEx
  10. 10MerckEx
  11. 11Network Partners Group2V
  12. 12Novartis Contract Manufacturing2V
  13. 13PfizerEx
  14. 14PLD Pharma Services2V
04Fig. 04 — By Tier
unspecified3
100% of 3